Skip to Content

Contact Information

Yolanda VillanuevaDirect Referrals to the Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program):
Yolanda Villanueva, RN, MSN, MBA
Patient Access Supervisor
(713) 792-1160.

When speaking with our nurses about treatment, please have the following information ready:

  • Patient name, telephone number and insurance information
  • Referring physician's name, office address, telephone and fax numbers
  • Diagnosis
  • Date of diagnosis
  • How the diagnosis was made (physical exam, biopsy, other)
  • What treatment, if any, has taken place
  • Over what time period the treatment has occurred
  • Specific medical and pathology reports may also be requested for review before your first visit.

Our nursing staff will work with you or your referring physician to expedite your first appointment. 

Read about What to Expect (pdf) once you are referred to the program.


Physical Address (for deliveries):
1400 Holcombe Blvd.
Unit 455
Faculty Center 8th Floor
Houston, TX 77030

Mailing Address:
UT MD Anderson Cancer Center
Department of Investigational Cancer Therapeutics, Unit 455
PO Box 301402
Houston, TX 77230-1402

Main Phone Number:


Observer Program 

We offer one short-term observer position each month.  

Appointments & Referrals

For a referral to clinical trials with a new targeted drug, call (713) 792-1160, or visit our Contact Information page.

© 2014 The University of Texas MD Anderson Cancer Center